{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:31:22Z","timestamp":1788262282807,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T00:00:00Z","timestamp":1326153600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2011.66","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T14:54:04Z","timestamp":1326207244000},"page":"e67-e67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["NMDA receptor genotypes associated with the vulnerability to develop dyskinesia"],"prefix":"10.1038","volume":"2","author":[{"given":"S A","family":"Ivanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J M","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Pechlivanoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M B","family":"Freidin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F Y","family":"Al Hadithy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E V","family":"Rudikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I A","family":"Zhukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N V","family":"Govorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V A","family":"Sorokina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O Y","family":"Fedorenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V M","family":"Alifirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A V","family":"Semke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R B J","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Wilffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,10]]},"reference":[{"key":"BFtp201166_CR1","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1176\/ajp.2006.163.8.1316","volume":"163","author":"JM Kane","year":"2006","unstructured":"Kane JM . Tardive dyskinesia circa 2006. Am J Psychiatry 2006; 163: 1316\u20131318.","journal-title":"Am J Psychiatry"},{"key":"BFtp201166_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/070674370505000907","volume":"50","author":"HC Margolese","year":"2005","unstructured":"Margolese HC, Chouinard G, Kolivakis TT, Beauclair L, Miller R . Tardive dyskinesia in the era of typical and atypical antipsychotics. part 1: Pathophysiology and mechanisms of induction. Can J Psychiatry 2005; 50: 541\u2013547.","journal-title":"Can J Psychiatry"},{"key":"BFtp201166_CR3","doi-asserted-by":"publisher","first-page":"c3109","DOI":"10.1136\/bmj.c3109","volume":"340","author":"MJ Novak","year":"2010","unstructured":"Novak MJ, Tabrizi SJ . Huntington's disease. BMJ 2010; 340: c3109.","journal-title":"BMJ"},{"key":"BFtp201166_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/pgmj.2006.054759","volume":"83","author":"B Thanvi","year":"2007","unstructured":"Thanvi B, Lo N, Robinson T . Levodopa-induced dyskinesia in parkinson's disease: Clinical features, pathogenesis, prevention and treatment. Postgrad Med J 2007; 83: 384\u2013388.","journal-title":"Postgrad Med J"},{"key":"BFtp201166_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","volume":"39","author":"AM Estrada Sanchez","year":"2008","unstructured":"Estrada Sanchez AM, Mejia-Toiber J, Massieu L . Excitotoxic neuronal death and the pathogenesis of huntington's disease. Arch Med Res 2008; 39: 265\u2013276.","journal-title":"Arch Med Res"},{"key":"BFtp201166_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","volume":"81","author":"MM Fan","year":"2007","unstructured":"Fan MM, Raymond LA . N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in huntington's disease. Prog Neurobiol 2007; 81: 272\u2013293.","journal-title":"Prog Neurobiol"},{"key":"BFtp201166_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1734-1140(10)70238-3","volume":"62","author":"P Kumar","year":"2010","unstructured":"Kumar P, Kalonia H, Kumar A . Huntington's disease: Pathogenesis to animal models. Pharmacol Rep 2010; 62: 1\u201314.","journal-title":"Pharmacol Rep"},{"key":"BFtp201166_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1155\/NP.2003.107","volume":"10","author":"HJ Groenewegen","year":"2003","unstructured":"Groenewegen HJ . The basal ganglia and motor control. Neural Plast 2003; 10: 107\u2013120.","journal-title":"Neural Plast"},{"key":"BFtp201166_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","volume":"17","author":"JB Lohr","year":"2003","unstructured":"Lohr JB, Kuczenski R, Niculescu AB . Oxidative mechanisms and tardive dyskinesia. CNS Drugs 2003; 17: 47\u201362.","journal-title":"CNS Drugs"},{"key":"BFtp201166_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00213-006-0348-9","volume":"185","author":"S Konitsiotis","year":"2006","unstructured":"Konitsiotis S, Tsironis C, Kiortsis DN, Evangelou A . Effects of N-methyl-D-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesias. Psychopharmacology (Berl) 2006; 185: 369\u2013377.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201166_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10048-004-0198-8","volume":"6","author":"L Arning","year":"2005","unstructured":"Arning L, Kraus PH, Valentin S, Saft C, Andrich J, Epplen JT . NR2A and NR2B receptor gene variations modify age at onset in huntington disease. Neurogenetics 2005; 6: 25\u201328.","journal-title":"Neurogenetics"},{"key":"BFtp201166_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/jmg.2006.045153","volume":"44","author":"JM Andresen","year":"2007","unstructured":"Andresen JM, Gayan J, Cherny SS, Brocklebank D, Alkorta-Aranburu G, Addis EA et al. Replication of twelve association studies for huntington's disease residual age of onset in large venezuelan kindreds. J Med Genet 2007; 44: 44\u201350.","journal-title":"J Med Genet"},{"key":"BFtp201166_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00439-007-0393-4","volume":"122","author":"L Arning","year":"2007","unstructured":"Arning L, Saft C, Wieczorek S, Andrich J, Kraus PH, Epplen JT . NR2A and NR2B receptor gene variations modify age at onset in huntington disease in a sex-specific manner. Hum Genet 2007; 122: 175\u2013182.","journal-title":"Hum Genet"},{"key":"BFtp201166_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","volume":"67","author":"NC Andreasen","year":"2010","unstructured":"Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC . Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 2010; 67: 255\u2013262.","journal-title":"Biol Psychiatry"},{"key":"BFtp201166_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/jcp.0b013e31814f1105","volume":"27","author":"AJ Loonen","year":"2007","unstructured":"Loonen AJ, van Praag HM . Measuring movement disorders in antipsychotic drug trials: the need to define a new standard. J Clin Psychopharmacol 2007; 27: 423\u2013430.","journal-title":"J Clin Psychopharmacol"},{"key":"BFtp201166_CR16","first-page":"486","volume":"39","author":"NR Schooler","year":"1982","unstructured":"Schooler NR, Kane JM . Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 1982; 39: 486\u2013487.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp201166_CR17","doi-asserted-by":"publisher","first-page":"W600","DOI":"10.1093\/nar\/gkp290","volume":"37","author":"Z Xu","year":"2009","unstructured":"Xu Z, Taylor JA . SNPinfo: Integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 2009; 37: W600\u2013W605.","journal-title":"Nucleic Acids Res"},{"key":"BFtp201166_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/gepi.20042","volume":"28","author":"C Kooperberg","year":"2005","unstructured":"Kooperberg C, Ruczinski I . Identifying interacting SNPs using monte carlo logic regression. Genet Epidemiol 2005; 28: 157\u2013170.","journal-title":"Genet Epidemiol"},{"key":"BFtp201166_CR19","first-page":"644","volume":"23","author":"JR Gonzalez","year":"2007","unstructured":"Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, Estivill X et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007; 23: 644\u2013645.","journal-title":"Bioinformatics"},{"key":"BFtp201166_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.neubiorev.2010.01.002","volume":"34","author":"SY Cherlyn","year":"2010","unstructured":"Cherlyn SY, Woon PS, Liu JJ, Ong WY, Tsai GC, Sim K . Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance. Neurosci Biobehav Rev 2010; 34: 958\u2013977.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtp201166_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.psychres.2006.08.007","volume":"153","author":"YJ Liou","year":"2007","unstructured":"Liou YJ, Wang YC, Chen JY, Bai YM, Lin CC, Liao DL et al. Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia. Psychiatry Res 2007; 153: 271\u2013275.","journal-title":"Psychiatry Res"},{"key":"BFtp201166_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/mds.23400","volume":"26","author":"JY Lee","year":"2011","unstructured":"Lee JY, Cho J, Lee EK, Park SS, Jeon BS . Differential genetic susceptibility in diphasic and peak-dose dyskinesias in parkinson's disease. Mov Disord 2011; 26: 73\u201379.","journal-title":"Mov Disord"},{"key":"BFtp201166_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1937-6448(10)81006-8","volume":"281","author":"MI Shadrina","year":"2010","unstructured":"Shadrina MI, Slominsky PA, Limborska SA . Molecular mechanisms of pathogenesis of parkinson's disease. Int Rev Cell Mol Biol 2010; 281: 229\u2013266.","journal-title":"Int Rev Cell Mol Biol"},{"key":"BFtp201166_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/mds.1112","volume":"16","author":"P Del Dotto","year":"2001","unstructured":"Del Dotto P, Pavese N, Gambaccini G, Bernardini S, Metman LV, Chase TN et al. Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study. Mov Disord 2001; 16: 515\u2013520.","journal-title":"Mov Disord"},{"key":"BFtp201166_CR25","first-page":"273","volume":"22","author":"M Merello","year":"1999","unstructured":"Merello M, Nouzeilles MI, Cammarota A, Leiguarda R . Effect of memantine (NMDA antagonist) on parkinson's disease: a double-blind crossover randomized study. Clin Neuropharmacol 1999; 22: 273\u2013276.","journal-title":"Clin Neuropharmacol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tp201166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tp201166","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:39:59Z","timestamp":1672954799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp201166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1]]}},"alternative-id":["BFtp201166"],"URL":"https:\/\/doi.org\/10.1038\/tp.2011.66","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,10]]},"assertion":[{"value":"1 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}